Nawaloka Hospitals PLC (COSE:NHL.N0000)
Sri Lanka flag Sri Lanka · Delayed Price · Currency is LKR
0.00
0.00 (0.00%)
Price not available due to exchange restrictions

Nawaloka Hospitals Income Statement

Millions LKR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
11,77811,01310,3799,30515,30211,828
Revenue Growth (YoY)
7.61%6.10%11.54%-39.19%29.38%30.90%
Cost of Revenue
5,3835,1344,7634,6707,4616,285
Gross Profit
6,3945,8785,6174,6357,8415,542
Selling, General & Admin
5,2174,9104,6183,8604,8563,753
Other Operating Expenses
-148.26-143.57-37.47258.91232.59-37.37
Operating Expenses
5,1784,8754,5924,7095,9274,042
Operating Income
1,2161,0031,025-73.461,9141,501
Interest Expense
-1,030-927.89-1,491-1,951-1,035-1,162
Interest & Investment Income
32.1328.9537.5658.5853.4648.27
Earnings From Equity Investments
223.04223.04148.53159.89--
Currency Exchange Gain (Loss)
4.34.333.73-102.56-215-24.4
Other Non Operating Income (Expenses)
-00--2.08-7.64-18.03
EBT Excluding Unusual Items
445.63331.79-247.01-1,911709.67344.61
Gain (Loss) on Sale of Investments
0.410.41----
Gain (Loss) on Sale of Assets
1.141.14---253.662.57
Asset Writedown
3.33.3----
Pretax Income
1,111336.64-247.01-1,911456.02347.17
Income Tax Expense
373.1280.2657.74527.67552.61-154.09
Net Income
738.1556.38-304.75-2,438-96.59501.26
Net Income to Common
738.1556.38-304.75-2,438-96.59501.26
Net Income Growth
3234.05%----3036.68%
Shares Outstanding (Basic)
1,4201,4101,4101,4101,4101,410
Shares Outstanding (Diluted)
1,4201,4101,4101,4101,4101,410
EPS (Basic)
0.520.04-0.22-1.73-0.070.36
EPS (Diluted)
0.520.04-0.22-1.73-0.070.36
EPS Growth
4201.44%----3456.31%
Free Cash Flow
-407.71792.792,0472,7521,259-65.36
Free Cash Flow Per Share
-0.290.561.451.950.89-0.05
Gross Margin
54.29%53.38%54.12%49.81%51.24%46.86%
Operating Margin
10.33%9.11%9.87%-0.79%12.51%12.69%
Profit Margin
6.27%0.51%-2.94%-26.21%-0.63%4.24%
Free Cash Flow Margin
-3.46%7.20%19.73%29.58%8.23%-0.55%
EBITDA
2,0251,8061,851754.972,7442,329
EBITDA Margin
17.19%16.40%17.83%8.11%17.93%19.69%
D&A For EBITDA
808.37802.41825.97828.43830.28828.33
EBIT
1,2161,0031,025-73.461,9141,501
EBIT Margin
10.33%9.11%9.87%-0.79%12.51%12.69%
Effective Tax Rate
33.58%83.25%--121.18%-
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.